Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP
References (18)
- et al.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate
Eur. J. Pharmacol.
(1985) - et al.
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
Life Sci.
(1985) - et al.
Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity
Brain Res.
(1991) - et al.
Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and non-protective agents
J. Pharmacol. Exp. Ther.
(1995) - et al.
Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate
Ann. Neurol.
(1994) - et al.
Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate
J. Neurochem.
(1993) - et al.
Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity
J. Neurochem.
(1994) - et al.
2-Deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in mouse brain
J. Neurochem.
(1993) - et al.
Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain
J. Neurochem.
(1991)
There are more references available in the full text version of this article.
Cited by (34)
The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism
2013, Experimental NeurologyCitation Excerpt :Mice were euthanized 15 h, 3 days or 7 days after treatment. We and others have shown that the mouse MPTP model produces extensive loss of striatal nerve terminals and of nigral DA neurons (Albers et al., 1996; German et al., 1996; Giovanni et al., 1994; Liang et al., 1996). The dose of captopril was selected based on previous studies (Munoz et al., 2006).
NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum
2000, Experimental NeurologyProtection of methamphetamine nigrostriatal toxicity by dietary selenium
1999, Brain ResearchStriatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid
1999, European Journal of PharmacologyThe selective vulnerability of striatopallidal neurons
1999, Progress in Neurobiology
Copyright © 1996 Published by Elsevier B.V.